Effectiveness of Autologous Skin Cell Suspension in Large Total Body Surface Area Burns: Analysis of Clinical Outcomes and Patient Charges
Journal of Burn Care & Research · 2024
DOI: 10.1093/jbcr/irae133 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Burn Care & Research, 2024. Verfasst von Djoni Elkady und 6 weiteren Autor:innen. Beteiligte Einrichtung: Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, USA. Hauptthemen laut MEDLINE: Burns, Skin Transplantation, Transplantation, Autologous. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Autologous skin cell suspension (ASCS) is an adjunct to conventional split-thickness skin grafts (STSG) for acute burns, enhancing healing and reducing donor site requirements. This study validates ASCS’s predictive benefits in hospital stay reduction and cost savings by analyzing outcomes and real-world charges post-ASCS implementation at a single institution. A retrospective study (2018-2022) included burn patients with ≥10% TBSA. The study population comprised 2 groups: burns treated either with a combination of ASCS ± STSG or with STSG alone. Outcomes included LOS, surgeries, infection, complications, days on antibiotics, and adjusted charge per TBSA. The ASCS ± STSG group demonstrated significantly shorter LOS (Mdn: 16.0 days, IQR: 10-26) than the STSG group (Mdn: 20.0 days, IQR: 14-36; P = .017), and fewer surgeries (Mdn: 1.0, IQR: 1-2) versus the STSG group (Mdn: 1.0, IQR: 1-4; P = .020). Postoperative complications were significantly lower in ASCS ± STSG (11% vs. 36%; P < .001). The STSG group had a longer distribution of antibiotic days (IQR: 0-7.0, min–max: 0-76) than the ASCS ± STSG group (IQR: 0-0, min–max: 0-37; P = .014). Wound infection incidence did not differ (P = .843). ASCS ± STSG showed a lower distribution of adjusted charge per TBSA (IQR: $10 788.5-$28 332.6) compared to the STSG group (IQR: $12 336.8-$29 507.3; P = .602) with a lower mean adjusted charge per TBSA ($20 995.0 vs. $24 882.3), although this was not statistically significant. ASCS ± STSG utilization demonstrated significant reductions in LOS, surgeries, postoperative complications, antibiotics, and potential cost savings. These findings underscore the practicality of integrating ASCS in burn management, offering substantial benefits to patients and healthcare institutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, USA.
- Department of Surgery, Summa Health System, Akron, OH 44304, USA.
- Adult and Pediatric Burn Institute and Department of Surgery, Akron Children's Hospital, Akron, OH 44308, USA.
- Rebecca D. Considine Research Institute, Akron, OH 44308, USA.
ORCID-Profile: Djoni Elkady, Brandon M Larson, Neil L McNinch, B Lou Richard
Zitieren
APA
Elkady, D., Larson, B. M., Sharma, S., McNinch, N. L., Beaucock, B., Richard, B. L., & Khandelwal, A. (2024). Effectiveness of Autologous Skin Cell Suspension in Large Total Body Surface Area Burns: Analysis of Clinical Outcomes and Patient Charges. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/irae133
Vancouver
Elkady D, Larson BM, Sharma S, McNinch NL, Beaucock B, Richard BL, et al. Effectiveness of Autologous Skin Cell Suspension in Large Total Body Surface Area Burns: Analysis of Clinical Outcomes and Patient Charges. Journal of Burn Care & Research. 2024. doi:10.1093/jbcr/irae133
BibTeX
@article{Elkady2024,
author = {Elkady, Djoni and Larson, Brandon M and Sharma, Steffi and McNinch, Neil L and Beaucock, Beverly and Richard, B Lou and Khandelwal, Anjay},
title = {Effectiveness of Autologous Skin Cell Suspension in Large Total Body Surface Area Burns: Analysis of Clinical Outcomes and Patient Charges},
journal = {Journal of Burn Care & Research},
year = {2024},
doi = {10.1093/jbcr/irae133}
}
EUVIMED